The pharmaceutical platform of a central enterprise has concentrated on development and production of anti-infection drugs for over 30 years, and is supported by the manufacturing corporation which possesses sterile preparations and API products which passed cGMP certification from European Union. The corporation has professional and effective teams on manufacturing, quality management and technological transformation, with rich experiences on cooperation with international famous pharmaceutical corporations.
The production line adopts international first-class manufacturing equipment, is equipped with on-line weighing unit to realize high-precision control, and utilizes automatic isolated transmission technique to reduce interference from manual operation. Advanced production and quality management levels and sterility assurance level make its annual comprehensive productivity reach 0.3 billion pieces of injections.
The manufacturing process of APIs is modularized highly, and can achieve automatic control with high precision; and these sterile API products may be packaged automatically, capped automatically and transmitted automatically, with real-time monitoring.
The production scales from 50-500L pilot test to mass manufacture certified by GMP may be customized flexibly to manufacturing of common chemical APIs. Furthermore, we have teams on development and technological transformation with rich experiences.
The production line of oral tablets/ capsules adopting international first-class equipment is established by virtue of the academician technology platform, and equipped with a technological transformation team with rich experiences, whose annual comprehensive productivity reaches 1 billion granules/tablets.
Taking localized production of biological products of international famous pharmaceutical manufacturers as a goal, using the state-of-the-art design idea, international equipment of international top brands and Advance Fill function, the production line achieves weighing each piece of product so as to guarantee the product quality and reduce drug solution consumption at the same time, and ensure 100% qualification rate, with an annual productivity of 50 million pieces (lyophilization- expanding space reserved).